| Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease A Douangamath, D Fearon, P Gehrtz, T Krojer, P Lukacik, CD Owen, ... Nature communications 11 (1), 5047, 2020 | 452 | 2020 |
| Site-specific biotinylation of purified proteins using BirA M Fairhead, M Howarth Site-Specific Protein Labeling: Methods and Protocols, 171-184, 2015 | 422 | 2015 |
| Rapid covalent-probe discovery by electrophile-fragment screening E Resnick, A Bradley, J Gan, A Douangamath, T Krojer, R Sethi, ... Journal of the American Chemical Society 141 (22), 8951-8968, 2019 | 253 | 2019 |
| SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids J Jansen, KC Reimer, JS Nagai, FS Varghese, GJ Overheul, M de Beer, ... Cell stem cell 29 (2), 217-231. e8, 2022 | 183 | 2022 |
| Direct electrochemistry of immobilized human cytochrome P450 2E1 A Fantuzzi, M Fairhead, G Gilardi Journal of the American Chemical Society 126 (16), 5040-5041, 2004 | 176 | 2004 |
| Bacterial tyrosinases: old enzymes with new relevance to biotechnology M Fairhead, L Thöny-Meyer New biotechnology 29 (2), 183-191, 2012 | 169 | 2012 |
| Molecular Lego: design of molecular assemblies of P450 enzymes for nanobiotechnology G Gilardi, YT Meharenna, GE Tsotsou, SJ Sadeghi, M Fairhead, ... Biosensors and Bioelectronics 17 (1-2), 133-145, 2002 | 135 | 2002 |
| Plug-and-play pairing via defined divalent streptavidins M Fairhead, D Krndija, ED Lowe, M Howarth Journal of molecular biology 426 (1), 199-214, 2014 | 110 | 2014 |
| Controlling multivalent binding through surface chemistry: model study on streptavidin GV Dubacheva, C Araya-Callis, A Geert Volbeda, M Fairhead, J Codée, ... Journal of the American Chemical Society 139 (11), 4157-4167, 2017 | 92 | 2017 |
| SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly M Fairhead, G Veggiani, M Lever, J Yan, D Mesner, CV Robinson, ... Journal of the American Chemical Society 136 (35), 12355-12363, 2014 | 79 | 2014 |
| Engineering silica particles as oral drug delivery vehicles SP Rigby, M Fairhead, CF van der Walle Current pharmaceutical design 14 (18), 1821-1831, 2008 | 70 | 2008 |
| Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego M Fairhead, S Giannini, EMJ Gillam, G Gilardi JBIC Journal of Biological Inorganic Chemistry 10, 842-853, 2005 | 68 | 2005 |
| High level production of tyrosinase in recombinant Escherichia coli Q Ren, B Henes, M Fairhead, L Thöny-Meyer BMC biotechnology 13, 1-10, 2013 | 66 | 2013 |
| Crystal structure and silica condensing activities of silicatein α–cathepsin L chimeras M Fairhead, KA Johnson, T Kowatz, SA McMahon, LG Carter, M Oke, ... Chemical Communications, 1765-1767, 2008 | 66 | 2008 |
| Role of the C‐terminal extension in a bacterial tyrosinase M Fairhead, L Thöny‐Meyer The FEBS journal 277 (9), 2083-2095, 2010 | 57 | 2010 |
| COVID moonshot: open science discovery of SARS-CoV-2 main protease inhibitors by combining crowdsourcing, high-throughput experiments, computational simulations, and machine … H Achdout, A Aimon, E Bar-David, GM Morris BioRxiv, 2020 | 49 | 2020 |
| Comparative study of three lactate oxidases from Aerococcus viridans for biosensing applications I Taurino, R Reiss, M Richter, M Fairhead, L Thöny-Meyer, G De Micheli, ... Electrochimica Acta 93, 72-79, 2013 | 46 | 2013 |
| Enzymatic cross-linking of gelatine with laccase and tyrosinase S Jus, I Stachel, M Fairhead, M Meyer, L Thoeny-Meyer, GM Guebitz Biocatalysis and Biotransformation 30 (1), 86-95, 2012 | 45 | 2012 |
| Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors COVID Moonshot Consortium, H Achdout, A Aimon, DS Alonzi, R Arbon, ... BioRxiv, 2020.10. 29.339317, 2020 | 38 | 2020 |
| Cross-linking and immobilisation of different proteins with recombinant Verrucomicrobium spinosum tyrosinase M Fairhead, L Thöny-Meyer Journal of biotechnology 150 (4), 546-551, 2010 | 36 | 2010 |
